Measure performance and management ability based on financial criteria

Nowadays, performance measurement of organizations and managers is noted and various indicators introduced as validation criteria. Hence, the scope of present research is access to financial criteria for evaluating management efficiency. So, for evaluating management efficiency based on former researches, we first used Demirjian et al (2012) Model to assess management efficiency in Iran. This model describes a management team who can make maximum income with present resources. In evaluating this model, we have 22 pharmaceutical firms confirmed in stock exchange of Tehran between years 1388 to 1394.The Research question test done with data fusion and multivariate regression and data envelopment analysis (DEA).
Research findings show that in this industry, Demerjian model cannot exhibit appropriate management efficiency because of Drug appraisal by Food & Drug Administration and monopoly in drug market.
Thus, by some changes in this model, we defined a management team which can create maximum value added with available sources for beneficiaries. Then we study management efficiency in those drug firms in which – concerning the results of WOUNG assay- use of this authority criteria is more obvious than Demerjian model.